Susquehanna International Group
CALA

Susquehanna International Group’s Calithera Biosciences, Inc CALA Stock Holding History

Susquehanna International Group’s Portfolio CALA Stock Details CALA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-2,310
Closed -$31K – 14488
2021
Q4 		$31K Sell
2,310
-3,040
-57% -$76.4K ﹤0.01% 12743
2021
Q3 		$233K Buy
5,350
+2,570
+92% +$111K ﹤0.01% 11161
2021
Q2 		$116K Sell
2,780
-7,895
-74% -$347K ﹤0.01% 12015
2021
Q1 		$517K Sell
10,675
-20,220
-65% -$1.18M ﹤0.01% 9385
2020
Q4 		$3.03M Buy
+30,895
New +$2.71M ﹤0.01% 4290
2020
Q3 		– Sell
-3,995
Closed -$422K – 11392
2020
Q2 		$422K Buy
3,995
+1,150
+40% +$137K ﹤0.01% 7730
2020
Q1 		$253K Buy
2,845
+1,575
+124% +$188K ﹤0.01% 8299
2019
Q4 		$145K Sell
1,270
-2,185
-63% -$164K ﹤0.01% 8961
2019
Q3 		$214K Buy
3,455
+1,555
+82% +$124K ﹤0.01% 8974
2019
Q2 		$148K Buy
1,900
+285
+18% +$32.3K ﹤0.01% 9388
2019
Q1 		$218K Buy
+1,615
New +$170K ﹤0.01% 7757
2018
Q4 		– Sell
-1,640
Closed -$172K – 10310
2018
Q3 		$172K Sell
1,640
-2,385
-59% -$227K ﹤0.01% 8334
2018
Q2 		$403K Sell
4,025
-1,705
-30% -$193K ﹤0.01% 7236
2018
Q1 		$722K Buy
5,730
+1,350
+31% +$211K ﹤0.01% 5895
2017
Q4 		$731K Buy
4,380
+265
+6% +$67.9K ﹤0.01% 5866
2017
Q3 		$1.3M Buy
4,115
+1,060
+35% +$334K ﹤0.01% 4773
2017
Q2 		$907K Sell
3,055
-230
-7% -$61.5K ﹤0.01% 5466
2017
Q1 		$759K Buy
+3,285
New +$567K ﹤0.01% 5709
2016
Q2 		– Sell
-640
Closed -$73K – 9570
2016
Q1 		$73K Sell
640
-425
-40% -$48.2K ﹤0.01% 8553
2015
Q4 		$163K Sell
1,065
-1,065
-50% -$160K ﹤0.01% 8585
2015
Q3 		$231K Buy
2,130
+715
+51% +$92.7K ﹤0.01% 8490
2015
Q2 		$202K Buy
+1,415
New +$328K ﹤0.01% 9276

Other funds holding CALA

BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TCMG
TSP Capital Management Group Summit, New Jersey $418M AUM 68.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's CALA Position: Q3 2022 in Review

Susquehanna International Group sold out of Calithera Biosciences, Inc (CALA) in Q3 2022, closing a stake of 10,177 shares — an estimated $25K sold.

Susquehanna International Group first reported a position in CALA in Q4 2014 and held it in 23 quarters. The position peaked at $2.41M in Q1 2018. 22 funds tracked by Wall St. Rank hold CALA as of Q3 2022.

  • Susquehanna International Group reported no remaining Calithera Biosciences, Inc position as of Q3 2022 after selling out during the quarter.
  • Susquehanna International Group sold 10,177 Calithera Biosciences, Inc shares in Q3 2022, an estimated $25K.
  • Susquehanna International Group first reported a position in Calithera Biosciences, Inc in Q4 2014 and held it in 23 quarters.
  • Susquehanna International Group's Calithera Biosciences, Inc position peaked at $2.41M in Q1 2018.
  • 22 funds tracked by Wall St. Rank held Calithera Biosciences, Inc as of Q3 2022.

Based on Susquehanna International Group's 13F filing for Q3 2022, filed 14 Nov 2022.